Avatrombopag
- PMID: 34813255
- Bookshelf ID: NBK575383
Avatrombopag
Excerpt
No information is available on the use of avatrombopag during breastfeeding. The manufacturer recommends avoiding breastfeeding during the use of avatrombopag and for at least 2 weeks after the last dose.
Similar articles
-
Avatrombopag: A Review in Thrombocytopenia.Drugs. 2021 Nov;81(16):1905-1913. doi: 10.1007/s40265-021-01613-y. Epub 2021 Oct 28. Drugs. 2021. PMID: 34709601 Free PMC article. Review.
-
Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2020 Oct;24(51):1-220. doi: 10.3310/hta24510. Health Technol Assess. 2020. PMID: 33108266 Free PMC article.
-
Dabrafenib.2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999914 Free Books & Documents. Review.
-
Dasatinib.2021 Jul 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Jul 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999860 Free Books & Documents. Review.
-
Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure.J Hepatol. 2014 Dec;61(6):1253-9. doi: 10.1016/j.jhep.2014.07.007. Epub 2014 Jul 15. J Hepatol. 2014. PMID: 25048952 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials